Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Salbutamol sulfate |
Is a |
False |
Salbutamol |
Inferred relationship |
Some |
|
Albuterol measurement (procedure) |
Component |
True |
Salbutamol |
Inferred relationship |
Some |
1 |
Salbutamol [inhalation preparations 2] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
|
Salbutamol-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salbutamol |
Inferred relationship |
Some |
1 |
Salbutamol-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salbutamol |
Inferred relationship |
Some |
1 |
Inhaled albuterol preparations |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
|
Salbutamol poisoning |
Causative agent (attribute) |
True |
Salbutamol |
Inferred relationship |
Some |
1 |
Accidental salbutamol poisoning |
Causative agent (attribute) |
False |
Salbutamol |
Inferred relationship |
Some |
|
Intentional salbutamol poisoning |
Causative agent (attribute) |
False |
Salbutamol |
Inferred relationship |
Some |
|
intoxication par le salbutamol d'intention indéterminée |
Causative agent (attribute) |
False |
Salbutamol |
Inferred relationship |
Some |
1 |
Salbutamol adverse reaction |
Causative agent (attribute) |
True |
Salbutamol |
Inferred relationship |
Some |
1 |
Allergy to salbutamol |
Causative agent (attribute) |
False |
Salbutamol |
Inferred relationship |
Some |
|
Salbutamol overdose |
Causative agent (attribute) |
True |
Salbutamol |
Inferred relationship |
Some |
1 |
Accidental salbutamol overdose (disorder) |
Causative agent (attribute) |
True |
Salbutamol |
Inferred relationship |
Some |
1 |
Intentional salbutamol overdose |
Causative agent (attribute) |
True |
Salbutamol |
Inferred relationship |
Some |
1 |
surdose de salbutamol d'intention indéterminée |
Causative agent (attribute) |
False |
Salbutamol |
Inferred relationship |
Some |
1 |
Salbutamol 4mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
|
Salbutamol 4mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
|
Salbutamol 8mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
|
Product containing precisely salbutamol 4 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
|
Salbutamol 8mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
|
Salbutamol 2mg/5mL sugar free syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
|
albutérol 5 mg/50 mL, pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
|
albutérol 250 microgrammes/5 mL, pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
|
albutérol 500 microgrammes/1 mL, pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
|
albutérol 5 mg/5 mL, perfusion intraveineuse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
|
Salbutamol 200micrograms/blister disks+disk inhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
|
Salbutamol 400micrograms/blister disks+disk inhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
|
Salbutamol 200micrograms/blister disks refill |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
|
Salbutamol 400micrograms/blister disks refill |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
|
Salbutamol 100micrograms breath-actuated aerosol inhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
|
Salbutamol 200micrograms breath-actuated dry powder inhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
|
Salbutamol 100micrograms breath-actuated dry powder inhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
|
Salbutamol 95micrograms breath-actuated dry powder inhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
|
Salbutamol 100micrograms CFC-free breath-actuated aerosol inhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
|
Salbutamol 5mg/2.5mL nebulization unit |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
|
Salbutamol 100micrograms inhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
|
Salbutamol 2.5mg/2.5mL nebulization unit |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
|
Salbutamol 200micrograms inhalation capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
|
Salbutamol 400micrograms inhalation capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
|
Salbutamol 100mg/20mL nebulizer solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
|
Salbutamol+ipratropium bromide 100micrograms/20micrograms inhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
|
Salbutamol+ipratropium bromide 2.5mg/500micrograms nebulization unit |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
|
Beclomethasone dipropionate+salbutamol 200micrograms/400micrograms inhalation capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
|
Beclomethasone dipropionate+salbutamol 100micrograms/200micrograms pediatric inhalation capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
|
Beclomethasone dipropionate+salbutamol 50micrograms/100micrograms inhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
|
Sodium cromoglycate+salbutamol 1mg/100micrograms inhaler+spacer |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
|
Sodium cromoglycate+salbutamol 1mg/100micrograms inhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
|
Salbutamol [obstetric] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
|
Beclomethasone dipropionate+salbutamol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
|
Product containing cromoglicate sodium and salbutamol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
|
Albuterol 200micrograms capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
|
Product containing precisely salbutamol (as salbutamol sulfate) 1 milligram/1 milliliter conventional release solution for inhalation (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
|
Salbutamol (as salbutamol sulfate) 830 microgram/mL solution for inhalation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
|
Albuterol sulfate 4mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
|
Albuterol 90mcg/inh aerosol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
|
Albuterol sulfate + ipratropium bromide 103mcg/18mcg aerosol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
|
Ipratropium bromide 167 microgram/mL and salbutamol (as salbutamol sulfate) 833 microgram/mL solution for inhalation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
|
Product containing salbutamol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salbutamol |
Inferred relationship |
Some |
1 |
Albuterol+ipratropium bromide |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
|
Salbutamol 100micrograms breath-actuated dry powder inhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
|
Salbutamol 100micrograms CFC-free inhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
|
Albuterol 0.0417% inhalation solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
|
Accidental salbutamol poisoning |
Causative agent (attribute) |
True |
Salbutamol |
Inferred relationship |
Some |
1 |
Intentional salbutamol poisoning |
Causative agent (attribute) |
True |
Salbutamol |
Inferred relationship |
Some |
1 |
Product containing ipratropium and salbutamol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salbutamol |
Inferred relationship |
Some |
2 |
Product containing beclometasone and salbutamol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salbutamol |
Inferred relationship |
Some |
2 |
Allergy to salbutamol |
Causative agent (attribute) |
True |
Salbutamol |
Inferred relationship |
Some |
1 |
Product containing precisely salbutamol 4 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
1 |
Product containing precisely salbutamol 4 milligram/1 each conventional release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Salbutamol |
Inferred relationship |
Some |
1 |
Salbutamol (as salbutamol sulfate) 2 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Salbutamol |
Inferred relationship |
Some |
1 |
Salbutamol sulfate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Salbutamol |
Inferred relationship |
Some |
|
Salbutamol (as salbutamol sulfate) 8 mg prolonged-release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Salbutamol |
Inferred relationship |
Some |
1 |
Product containing precisely salbutamol (as salbutamol sulfate) 8 milligram/1 each prolonged-release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Salbutamol |
Inferred relationship |
Some |
1 |
Product containing precisely salbutamol (as salbutamol sulfate) 4 milligram/1 each prolonged-release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Salbutamol |
Inferred relationship |
Some |
1 |
Salbutamol (as salbutamol sulfate) 4 mg prolonged-release oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Salbutamol |
Inferred relationship |
Some |
1 |
Product containing precisely salbutamol 4 milligram/1 each conventional release oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Salbutamol |
Inferred relationship |
Some |
1 |
Product containing cromoglicic acid and salbutamol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salbutamol |
Inferred relationship |
Some |
2 |
Salbutamol-containing product in pulmonary dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salbutamol |
Inferred relationship |
Some |
1 |
Salbutamol (as salbutamol sulfate) 400 microgram/mL oral solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Salbutamol |
Inferred relationship |
Some |
1 |
Product containing precisely salbutamol 200 microgram/1 actuation conventional release powder for inhalation (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Salbutamol |
Inferred relationship |
Some |
1 |
Product containing precisely salbutamol 200 microgram/1 actuation conventional release powder for inhalation (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Salbutamol |
Inferred relationship |
Some |
1 |
Salbutamol (as salbutamol sulfate) 95 microgram/actuation powder for inhalation |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Salbutamol |
Inferred relationship |
Some |
1 |
Salbutamol (as salbutamol sulfate) 100 microgram/actuation powder for inhalation |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Salbutamol |
Inferred relationship |
Some |
1 |
Albuterol (as albuterol sulfate) 100 microgram/actuation pressurized suspension for inhalation |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Salbutamol |
Inferred relationship |
Some |
1 |
Product containing precisely salbutamol (as salbutamol sulfate) 500 microgram/1 milliliter conventional release solution for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Salbutamol |
Inferred relationship |
Some |
1 |
Product containing precisely salbutamol (as salbutamol sulfate) 5 milligram/50 milliliter conventional release solution for infusion vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Salbutamol |
Inferred relationship |
Some |
1 |
Product containing precisely salbutamol (as salbutamol sulfate) 5 milligram/5 milliliter conventional release solution for infusion ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Salbutamol |
Inferred relationship |
Some |
1 |
Product containing only beclometasone and salbutamol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salbutamol |
Inferred relationship |
Some |
2 |
Product containing only cromoglicic acid and salbutamol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salbutamol |
Inferred relationship |
Some |
2 |
Ipratropium and salbutamol only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salbutamol |
Inferred relationship |
Some |
2 |
Salbutamol only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salbutamol |
Inferred relationship |
Some |
1 |
Product containing only salbutamol in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salbutamol |
Inferred relationship |
Some |
1 |
Product containing only salbutamol in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salbutamol |
Inferred relationship |
Some |
1 |
Product containing only salbutamol in pulmonary dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salbutamol |
Inferred relationship |
Some |
1 |
Product containing precisely salbutamol (as salbutamol sulfate) 1 milligram/1 milliliter conventional release solution for infusion (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Salbutamol |
Inferred relationship |
Some |
1 |
Salbutamol (as salbutamol sulfate) 100 microgram/mL solution for infusion |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Salbutamol |
Inferred relationship |
Some |
1 |
Salbutamol (as salbutamol sulfate) 500 microgram/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Salbutamol |
Inferred relationship |
Some |
1 |
Salbutamol (as salbutamol sulfate) 4 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Salbutamol |
Inferred relationship |
Some |
1 |
Product containing precisely salbutamol (as salbutamol sulfate) 1 milligram/1 milliliter conventional release solution for inhalation (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Salbutamol |
Inferred relationship |
Some |
1 |
Salbutamol (as salbutamol sulfate) 830 microgram/mL solution for inhalation |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Salbutamol |
Inferred relationship |
Some |
1 |